ClariVest Asset Management’s Cantel Medical Corporation CMD Stock Holding History

ClariVest Asset Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-63,204	Closed	-$5.05M	–	860
2021 Q1	$5.05M	Buy	63,204 +53,685	+564%	+$4.19M	0.18%	110
2020 Q4	$751K	Buy	+9,519	New	+$558K	0.03%	312
2013 Q4	–	Sell	-56,245	Closed	-$1.79M	–	665
2013 Q3	$1.79M	Sell	56,245 -7,501	-12%	-$199K	0.08%	173
2013 Q2	$1.44M	Buy	+63,746	New	+$1.38M	0.06%	187

ClariVest Asset Management's CMD Position: Q2 2021 in Review

ClariVest Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 63,204 shares — an estimated $5.05M sold.

ClariVest Asset Management first reported a position in CMD in Q2 2013 and held it in 4 quarters. The position peaked at $5.05M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

ClariVest Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
ClariVest Asset Management sold 63,204 Cantel Medical Corporation shares in Q2 2021, an estimated $5.05M.
ClariVest Asset Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 4 quarters.
ClariVest Asset Management's Cantel Medical Corporation position peaked at $5.05M in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on ClariVest Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.